A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenstr öm's Macroglobulinemia

Condition:   Waldenström's Macroglobulinemia Intervention:   Drug: zanubrutinib,bendamustine,rituximab Sponsors:   Shanghai Changzheng Hospital;   RenJi Hospital;   Huashan Hospital;   Shanghai 6th People's Hospital;   Huadong Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials